Brand Name: Klonopin
Outside U.S., Brand Names also known as: Clonex; Iktorivil; Landsen; Lonazep;
Paxam; Rivotril
Clonazepam is an anti-anxiety medication used to treat panic disorder and seizures. Detailed info on uses, dosage and side-effects of Clonazepam below.
Contents:
Description
Pharmacology
Indications and Usage
Contraindications
Warnings
Precautions
Drug Interactions
Adverse Reactions
Overdose
Dosage
Klonopin is a benzodiazepine used to treat panic disorder and seizures. It may
also be used to treat certain emotional disorders or other conditions as
determined by your doctor.
In humans it is capable of suppressing the spike and wave discharge in absence
seizures (petit mal) and decreasing the frequency, amplitude, duration and
spread of discharge in minor motor seizures.
Single oral dose administration of Clonazepam to humans gave maximum blood
levels of drug, in most cases, within one to two hours.
Clonazepam (Klonopin) is useful alone or as an adjunct in the treatment of the
Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In
patients with absence seizures (petit mal) who have failed to respond to
succinimides, clonazepam may be useful.
In some studies, up to 30% of patients have shown a loss of anticonvulsant
activity, often within three months of administration. In some cases, dosage
adjustment may reestablish efficacy.
Clonazepam should not be used in patients with a history of sensitivity to
benzodiazepines, nor in patients with clinical or biochemical evidence of
significant liver disease. It may be used in patients with open angle glaucoma
who are receiving appropriate therapy, but is contraindicated in acute narrow
angle glaucoma.
Interference with Cognitive or Motor Performance: Since clonazepam
produces CNS depression, patients receiving this drug should be cautioned
against engaging in hazardous occupations requiring mental alertness, such as
operating machinery or driving a motor vehicle. They should also be warned about
the concomitant use of alcohol or other CNS-depressant drugs during clonazepam
therapy.
Pregnancy and Withdrawal: The effects of clonazepam in human pregnancy
and nursing infants are unknown.
Use of clonazepam in women of childbearing potential should be considered only
when the clinical situation warrants the risk. Mothers receiving clonazepam
should not breast feed their infants.
Recent reports suggest an association between the use of anticonvulsant drugs by
women with epilepsy and an elevated incidence of birth defects in children born
to these women. Data are more extensive with respect to diphenylhydantoin and
phenobarbital, but these are also the most commonly prescribed anticonvulsants;
less systematic or anecdotal reports suggest a possible similar association with
the use of all known anticonvulsant drugs.
Usage in Children: Because of the possibility that adverse effects on
physical or mental development could become apparent only after many years, a
benefit-risk consideration of the long-term use of clonazepam is important in
pediatric patients.
Dependency and Withdrawal:
Withdrawal symptoms of the barbiturate type have occurred after the
discontinuation of benzodiazepines.
Seizures: When used in patients in whom several different types of
seizure disorders coexist, clonazepam may increase the incidence or precipitate
the onset of generalized tonic-clonic seizures (grand mal). This may require the
addition of appropriate anticonvulsants or an increase in their dosages. The
concomitant use of valproic acid and clonazepam may produce absence status.
The abrupt withdrawal of clonazepam, particularly in those patients on
long-term, high-dose therapy, may precipitate status epilepticus. Therefore,
when discontinuing clonazepam, gradual withdrawal is essential. While clonazepam
is being gradually withdrawn, the simultaneous substitution of another
anticonvulsant may be indicated. Metabolites of clonazepam are excreted by the
kidneys; to avoid their excess accumulation, caution should be exercised in the
administration of the drug to patients with impaired renal function.
Clonazepam may produce an increase in salivation. This should be considered
before giving the drug to patients who have difficulty handling secretions.
Because of this and the possibility of respiratory depression, clonazepam should
be used with caution in patients with chronic respiratory diseases.
Drug Interactions
The CNS-depressant action of the benzodiazepine class of drugs may be
potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics,
antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes
of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic
antidepressants, and by other anticonvulsant drugs.
BEFORE USING THIS MEDICINE: INFORM YOUR DOCTOR OR
PHARMACIST of all prescription and over-the-counter medicine that you are
taking. This includes clozapine, disulfiram, omeprazole, and valproic acid.
Inform your doctor of any other medical conditions, allergies, pregnancy, or
breast-feeding.
The most frequently occurring side effects of clonazepam are referable to CNS
depression. Experience to date has shown that drowsiness has occurred in
approximately 50% of patients and ataxia in approximately 30%. In some cases,
these may diminish with time; behavior problems have been noted in approximately
25% of patients. Others, listed by system are:
Neurologic: Abnormal eye movements, aphonia, choreiform movements, coma,
diplopia, dysarthria, dysdiadochokinesis, "glassy-eyed" appearance, headache,
hemiparesis, hypotonia, nystagmus, respiratory depression, slurred speech,
tremor, vertigo.
Psychiatric: Confusion, depression, amnesia, hallucinations, hysteria,
increased libido, insomnia, psychosis, suicidal attempt (the behavior effects
are more likely to occur in patients with a history of psychiatric
disturbances).
Respiratory: Chest congestion, rhinorrhea, shortness of breath,
hypersecretion in upper respiratory passages.
Cardiovascular: Palpitations.
Dermatologic: Hair loss, hirsutism, skin rash, ankle and facial edema.
Gastrointestinal: Anorexia, coated tongue, constipation, diarrhea, dry
mouth, encopresis, gastritis, hepatomegaly, increased appetite, nausea, sore
gums.
Genitourinary: Dysuria, enuresis, nocturia, urinary retention.
Musculoskeletal: Muscle weakness, pains.
Miscellaneous: Dehydration, general deterioration, fever, lymphadenopathy,
weight loss or gain.
Hematopoietic: Anemia, leukopenia, thrombocytopenia, eosinophilia.
Hepatic: Transient elevations of serum transaminases and alkaline
phosphatase.
Drug Abuse and Dependence: Withdrawal symptoms, similar in character
to those noted with barbiturates and alcohol (e.g., convulsions, psychosis,
hallucinations, behavioral disorder, tremor, abdominal and muscle cramps) have
occurred following abrupt discontinuance of clonazepam. The more severe
withdrawal symptoms have usually been limited to those patients who received
excessive doses over an extended period of time. Generally milder withdrawal
symptoms (e.g., dysphoria and insomnia) have been reported following abrupt
discontinuance of benzodiazepines taken continuously at therapeutic levels for
several months. Consequently, after extended therapy, abrupt discontinuation
should generally be avoided and a gradual dosage tapering schedule followed.
Addiction-prone individuals (such as drug addicts or alcoholics) should be under
careful surveillance when receiving clonazepam or other psychotropic agents
because of the predisposition of such patients to habituation and dependence.
Signs and Symptoms
Symptoms of clonazepam overdosage, like those produced by other CNS depressants,
include somnolence, confusion, coma and diminished reflexes.
Treatment
If you or someone you know may have used more than the recommended dose of this
medicine, contact your local poison control center or emergency room
immediately.
Treatment includes monitoring of respiration, pulse and blood pressure, general
supportive measures and immediate gastric lavage. Intravenous fluids should be
administered and an adequate airway maintained. Hypotension may be combated by
the use of levarterenol or metaraminol. Methylphenidate or caffeine and sodium
benzoate may be given to combat CNS depression. Dialysis is of no known value.
Do not exceed the recommended dosage or take this medicine for longer than
prescribed. Exceeding the recommended dose or taking this medicine for longer
than prescribed may be habit forming.
- Follow the directions for using this medicine provided by your doctor.
- Store this medicine at room temperature, away from heat and light.
- Take this medicine everyday at evenly spaced intervals.
- If you miss a dose of this medicine and you are using it regularly, take
it as soon as possible. If it is almost time for your next dose, skip the
missed dose and go back to your regular dosing schedule. Do not take 2 doses
at once.
- This medicine may be taken with food if it upsets your stomach.
Additional Information: Do not share this medicine with others for
whom it was not prescribed. Do not use this medicine for other health
conditions. Keep this medicine out of the reach of children.
Adults: The initial dose for adults should not exceed 1.5 mg/day
divided into three doses. Dosage may be increased in increments of 0.5 to 1 mg
every three days until seizures are adequately controlled or until side effects
preclude any further increase. Maintenance dosage must be individualized for
each patient depending upon response. Maximum recommended daily dose is 20 mg.
The use of multiple anticonvulsants may result in an increase of depressant
adverse effects. This should be considered before adding clonazepam to an
existing anticonvulsant regimen.
Children: Clonazepam is administered orally. In order to minimize
drowsiness, the initial dose for infants and children (up to 10 years of age or
30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to
exceed 0.05 mg/kg/day given in two or three divided doses. Dosage should be
increased by no more than 0.25 to 0.5 mg every third day until a daily
maintenance dose of 0.1 to 0.2 mg/kg of body weight has been reached unless
seizures are controlled or side effects preclude further increase. Whenever
possible, the daily dose should be divided into three equal doses. If doses are
not equally divided, the largest dose should be given before retiring.
How Supplied
Klonopin is available as scored tablets containing 0.5 mg, 1 mg or 2 mg
clonazepam.
The information in this monograph is not intended to cover all possible uses,
directions, precautions, drug interactions or adverse effects. This information
is generalized and is not intended as specific medical advice. If you have
questions about the medicines you are taking or would like more information,
check with your doctor, pharmacist, or nurse.
top .
send to friend .
medications homepage
Reviewed: 01/2006
|